122 related articles for article (PubMed ID: 38305049)
1. Circulating leptin is associated with adverse vascular changes in young adult survivors of childhood cancer.
Broberg O; Feldreich T; Weismann CG; Øra I; Wiebe T; Ärnlöv J; Liuba P
Cardiol Young; 2024 Feb; ():1-9. PubMed ID: 38305049
[TBL] [Abstract][Full Text] [Related]
2. Anthracycline causes impaired vascular endothelial function and aortic stiffness in long term survivors of childhood cancer.
Jenei Z; Bárdi E; Magyar MT; Horváth A; Paragh G; Kiss C
Pathol Oncol Res; 2013 Jul; 19(3):375-83. PubMed ID: 23242567
[TBL] [Abstract][Full Text] [Related]
3. Local arterial stiffness measured by ultrafast ultrasound imaging in childhood cancer survivors treated with anthracyclines.
Rasouli R; Baranger J; Slorach C; Hui W; Venet M; Nguyen MB; Henry M; Gopaul J; Nathan PC; Mertens L; Villemain O
Front Cardiovasc Med; 2023; 10():1150214. PubMed ID: 37346288
[TBL] [Abstract][Full Text] [Related]
4. Characterization of Cardiac, Vascular, and Metabolic Changes in Young Childhood Cancer Survivors.
Broberg O; Øra I; Wiebe T; Weismann CG; Liuba P
Front Pediatr; 2021; 9():764679. PubMed ID: 34956978
[No Abstract] [Full Text] [Related]
5. Growth hormone deficiency predicts cardiovascular risk in young adults treated for acute lymphoblastic leukemia in childhood.
Link K; Moëll C; Garwicz S; Cavallin-Ståhl E; Björk J; Thilén U; Ahrén B; Erfurth EM
J Clin Endocrinol Metab; 2004 Oct; 89(10):5003-12. PubMed ID: 15472198
[TBL] [Abstract][Full Text] [Related]
6. Medical interventions for treating anthracycline-induced symptomatic and asymptomatic cardiotoxicity during and after treatment for childhood cancer.
Sieswerda E; van Dalen EC; Postma A; Cheuk DK; Caron HN; Kremer LC
Cochrane Database Syst Rev; 2011 Sep; (9):CD008011. PubMed ID: 21901716
[TBL] [Abstract][Full Text] [Related]
7. Subcutaneous adipose tissue plays a beneficial effect on subclinical atherosclerosis in young survivors of acute lymphocytic leukemia.
Siviero-Miachon AA; Spinola-Castro AM; de Martino Lee ML; de Castro Monteiro CM; de Camargo Carvalho AC; Calixto AR; Geloneze B; Guerra-Junior G
Vasc Health Risk Manag; 2015; 11():479-88. PubMed ID: 26316772
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular Testing Detects Underlying Dysfunction in Childhood Leukemia Survivors.
Long TM; Lee F; Lam K; Wallman KE; Walwyn TS; Choong CS; Naylor LH
Med Sci Sports Exerc; 2020 Mar; 52(3):525-534. PubMed ID: 31652239
[TBL] [Abstract][Full Text] [Related]
9. Ventricular-Arterial Coupling in Breast Cancer Patients After Treatment With Anthracycline-Containing Adjuvant Chemotherapy.
Koelwyn GJ; Lewis NC; Ellard SL; Jones LW; Gelinas JC; Rolf JD; Melzer B; Thomas SM; Douglas PS; Khouri MG; Eves ND
Oncologist; 2016 Feb; 21(2):141-9. PubMed ID: 26764251
[TBL] [Abstract][Full Text] [Related]
10. Subclinical Cardiac Dysfunction in Childhood Cancer Survivors on 10-Years Follow-Up Correlates With Cumulative Anthracycline Dose and Is Best Detected by Cardiopulmonary Exercise Testing, Circulating Serum Biomarker, Speckle Tracking Echocardiography, and Tissue Doppler Imaging.
Wolf CM; Reiner B; Kühn A; Hager A; Müller J; Meierhofer C; Oberhoffer R; Ewert P; Schmid I; Weil J
Front Pediatr; 2020; 8():123. PubMed ID: 32296665
[No Abstract] [Full Text] [Related]
11. CIMT does not identify early vascular changes in childhood acute lymphoblastic leukemia survivors.
Ociepa T; Posio W; Sawicki M; Urasiński T
Adv Clin Exp Med; 2020 Feb; 29(2):243-249. PubMed ID: 32073764
[TBL] [Abstract][Full Text] [Related]
12. Ceramides: a potential cardiovascular biomarker in young adult childhood cancer survivors?
Broberg O; Weismann CG; Øra I; Wiebe T; Laaksonen R; Liuba P
Eur Heart J Open; 2024 Mar; 4(2):oeae026. PubMed ID: 38659666
[TBL] [Abstract][Full Text] [Related]
13. Resting and exercise arterial dysfunction in anthracycline-treated adult survivors of childhood cancers.
Li VW; Liu AP; Ho KK; Yau JP; Cheuk DK; Cheung YF
Cardiooncology; 2018; 4():9. PubMed ID: 32154007
[TBL] [Abstract][Full Text] [Related]
14. Cardiac complications in childhood cancer survivors treated with anthracyclines.
Franco VI; Lipshultz SE
Cardiol Young; 2015 Aug; 25 Suppl 2():107-16. PubMed ID: 26377717
[TBL] [Abstract][Full Text] [Related]
15. Is Carotid Stiffness a Possible Surrogate for Stroke in Long-term Survivors of Childhood Cancer after Neck Radiotherapy?
Zaletel LZ; Popit M; Zaletel M
Radiol Oncol; 2018 Jun; 52(2):136-142. PubMed ID: 30018516
[TBL] [Abstract][Full Text] [Related]
16. Circulating leptin levels are associated with adiposity in survivors of childhood brain tumors.
Sims ED; Jennings WJ; Empringham B; Fleming A; Portwine C; Johnston DL; Zelcer SM; Rassekh SR; Burrow S; Thabane L; Samaan MC
Sci Rep; 2020 Mar; 10(1):4711. PubMed ID: 32170116
[TBL] [Abstract][Full Text] [Related]
17. Non-invasive assessment of vascular system function and damage induced by anthracycline treatment in the pediatric cancer survivors.
Budinskaya K; Puchnerová V; Svačinová J; Novák J; Hrstková H; Nováková M; Pekařová A; Pekař M; Nováková Z
Physiol Res; 2017 Dec; 66(Suppl 4):S553-S560. PubMed ID: 29355384
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of traditional and novel measures of cardiac function to detect anthracycline-induced cardiotoxicity in survivors of childhood cancer.
Dietz AC; Sivanandam S; Konety S; Kaufman CL; Gage RM; Kelly AS; Neglia JP; Mulrooney DA
J Cancer Surviv; 2014 Jun; 8(2):183-9. PubMed ID: 24317971
[TBL] [Abstract][Full Text] [Related]
19. The Effect of Atorvastatin on Vascular Function and Structure in Young Adult Survivors of Childhood Cancer: A Randomized, Placebo-Controlled Pilot Clinical Trial.
Marlatt KL; Steinberger J; Rudser KD; Dengel DR; Sadak KT; Lee JL; Blaes AH; Duprez DA; Perkins JL; Ross JA; Kelly AS
J Adolesc Young Adult Oncol; 2019 Aug; 8(4):442-450. PubMed ID: 28853979
[No Abstract] [Full Text] [Related]
20. Radiotherapy-related arterial intima thickening and plaque formation in childhood cancer survivors detected with very-high resolution ultrasound during young adulthood.
Vatanen A; Sarkola T; Ojala TH; Turanlahti M; Jahnukainen T; Saarinen-Pihkala UM; Jahnukainen K
Pediatr Blood Cancer; 2015 Nov; 62(11):2000-6. PubMed ID: 26052933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
